SIRT5 and neoplasm: We found that SIRT5 overexpression was associated positively with larger tumor size (P = 0.036), increased lymph node metastasis (P = 0.016), advanced tumor stage (P = 0.038), and American Joint Committee on Cancer (AJCC) stage (P = 0.005).